Exploring Predictive Oncology Inc. (POAI) Investor Profile: Who’s Buying and Why?

Ever wondered who's investing in Predictive Oncology Inc. (POAI) and what's driving their decisions? As of April 2025, the company, which leverages AI to advance cancer therapies, faces a complex financial landscape, reporting a $10.8 million loss from continuing operations on revenue of $1.6 million for the fiscal year 2024. With institutional investors holding approximately 2.22% of the company's stock, and insiders owning about 1.57%, understanding the motivations behind these investments becomes crucial, especially given the backdrop of a potential merger with Renovaro Inc. and a significant decrease in cash reserves from $8.7 million in 2023 to $734,673 at the end of 2024. What does this mean for the future of POAI and its investors?

Predictive Oncology Inc. (POAI) Who Invests in [Company Name] and Why?

Understanding the investor profile of Predictive Oncology Inc. (POAI) provides valuable insights into the market's perception of the company and its future prospects. Investors are generally categorized into retail investors, institutional investors, and insiders, each having different motivations and strategies.

Here's a breakdown of the key investor types in Predictive Oncology Inc. (POAI):

• Retail Investors: These are individual investors who buy and sell shares for their own accounts. According to recent data, retail investors hold a significant portion of POAI's stock. TipRanks data indicates that approximately 95.24% of Predictive Oncology Inc. (POAI) stock is held by retail investors.
• Institutional Investors: These are entities that invest on behalf of others, such as mutual funds, pension funds, and hedge funds. Fintel reports that Predictive Oncology Inc. (US:POAI) has 24 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 290,754 shares.
• Insiders: These are the company's executives and board members who own shares of the company. According to Simply Wall St, insiders own 106,164 shares, representing 1.47% ownership.

Institutional investors in Predictive Oncology Inc. include:

• Vanguard Group Inc
• VEXMX - Vanguard Extended Market Index Fund Investor Shares
• Geode Capital Management, Llc
• FSMAX - Fidelity Extended Market Index Fund
• Csenge Advisory Group
• Jane Street Group, Llc
• XTX Topco Ltd
• State Street Corp
• Two Sigma Investments, Lp
• Carnegie Mellon University

The motivations behind investing in Predictive Oncology Inc. can vary:

• Growth Prospects: Investors may be attracted to Predictive Oncology Inc. due to its focus on AI-driven cancer research and personalized medicine. The company's technology, which combines a biobank of over 150,000 tumor samples with artificial intelligence, aims to improve drug discovery and development.
• Market Position: Predictive Oncology Inc. operates in the medical instruments and supplies sector. Its acquisition by Renovaro in January 2024 aimed to combine complementary AI/ML platforms to enhance cancer drug discovery and patient outcomes.

Typical investment strategies observed among investors include:

• Long-Term Holding: Some institutional investors, such as Vanguard Group and Geode Capital Management, may adopt a long-term holding strategy, reflecting confidence in the company's future growth.
• Short-Term Trading: Given the stock's volatility, some investors may engage in short-term trading strategies to capitalize on price fluctuations.

Here's a summary of the ownership breakdown based on available data:

It's important to note that institutional holdings can influence a company's stock price due to their trading patterns. The Fund Sentiment Score, which identifies companies with high levels of institutional accumulation, can be a useful metric for investors.

For additional information, you can explore Predictive Oncology Inc.'s history, mission, and ownership structure: Predictive Oncology Inc. (POAI): History, Ownership, Mission, How It Works & Makes Money

Predictive Oncology Inc. (POAI) Institutional Ownership and Major Shareholders of Predictive Oncology Inc. (POAI)

Understanding the institutional ownership and major shareholders of Predictive Oncology Inc. (POAI) is crucial for investors seeking insights into the company's stability, strategic direction, and potential stock performance. Institutional investors often have significant resources and conduct thorough research, making their investment decisions a noteworthy signal for the broader market. Here’s a detailed look at POAI's investor profile:

Top Institutional Investors: Identifying the largest institutional investors provides a glimpse into who holds the most significant stakes in Predictive Oncology Inc. (POAI). These institutions can exert considerable influence on the company's stock price and strategic decisions. While specific, up-to-the-minute shareholding data fluctuates, examining recent filings and reports can reveal the major players.

As of the latest available data, the top institutional investors in Predictive Oncology Inc. (POAI) typically include a mix of investment firms, hedge funds, and asset management companies. Here's a general overview based on recent reports:

• Vanguard Group: Often holds a significant number of shares in publicly traded companies, including POAI, through its various index funds and ETFs.
• BlackRock Fund Advisors: Another major asset manager with substantial holdings in numerous companies across different sectors.
• Geode Capital Management LLC: Known for its quantitative investment strategies and broad portfolio of holdings.
• Citadel Advisors LLC: A well-known hedge fund that may have positions in POAI as part of its trading strategies.
• Susquehanna International Group LLP: Another key player in the financial industry that could hold shares in POAI.

Changes in Ownership: Monitoring whether institutional investors have increased or decreased their positions in Predictive Oncology Inc. (POAI) can provide valuable insights. An increase in institutional ownership may signal confidence in the company's future prospects, while a decrease could indicate concerns or a shift in investment strategy.

Recent changes in ownership can be gleaned from regulatory filings such as 13F filings, which institutional investment managers with over $100 million in assets under management are required to file quarterly. These filings disclose their equity holdings and can reveal trends in institutional ownership. Keep an eye on these filings to understand if major investors are accumulating or divesting shares of POAI.

Impact of Institutional Investors: The presence and activities of large institutional investors can significantly impact Predictive Oncology Inc. (POAI). Their actions can influence the company's stock price, trading volume, and overall market perception.

Here’s how institutional investors can play a role:

• Stock Price: Large purchases by institutional investors can drive up the stock price due to increased demand, while significant sales can exert downward pressure.
• Company Strategy: Institutional investors often engage with company management to discuss strategy, performance, and governance issues. Their feedback and voting power can influence corporate decisions.
• Market Confidence: High institutional ownership can boost market confidence in a company, attracting additional investors and potentially lowering the cost of capital.

For further insights into Predictive Oncology Inc. (POAI)'s financial standing, you might find this resource helpful: Breaking Down Predictive Oncology Inc. (POAI) Financial Health: Key Insights for Investors

Keeping a close watch on these aspects of institutional ownership can provide a more informed perspective on Predictive Oncology Inc. (POAI)'s potential and the factors driving its market performance.

Below is a sample table, for illustrative purposes, demonstrating how institutional ownership data might be organized. Please note that the data below is not real and is only for demonstration.

This table helps visualize the ownership structure and recent changes, offering a clearer picture of institutional investor activity in POAI.

Predictive Oncology Inc. (POAI) Key Investors and Their Impact on Predictive Oncology Inc. (POAI)

Understanding the investor profile of Predictive Oncology Inc. (POAI) is crucial for grasping the company's dynamics and potential future trajectory. Key investors can significantly influence company decisions and stock performance through their holdings and strategic moves.

While specific, real-time details on all current investors and their precise holdings in Predictive Oncology Inc. (POAI) as of April 2025 are not available without access to specialized financial databases, we can explore the types of investors that are typically relevant for a company like Predictive Oncology Inc. (POAI), and discuss how their actions can impact the company.

Predictive Oncology Inc. (POAI) might attract a mix of institutional and individual investors, each with different investment strategies and levels of influence:

• Institutional Investors: These include mutual funds, hedge funds, pension funds, and insurance companies. They often hold large blocks of shares and can exert considerable influence on company management and strategy. Their investment decisions are typically driven by in-depth financial analysis and long-term growth prospects.
• Individual Investors: These can range from retail investors to high-net-worth individuals. Their impact varies depending on the size of their holdings and their activism.
• Activist Investors: These investors take large positions in a company and then actively campaign for changes they believe will increase shareholder value. This could involve pushing for strategic shifts, operational improvements, or changes in management.

The influence of these investors can manifest in several ways:

• Stock Movements: Large purchases or sales by institutional investors can cause significant price fluctuations.
• Corporate Governance: Major shareholders can influence board elections and key decisions such as mergers, acquisitions, and executive compensation.
• Strategic Direction: Activist investors may publicly advocate for specific changes, which can pressure management to take action.

Given the dynamic nature of investor holdings, staying informed about recent moves is essential. Here’s what to look for:

• Major Stake Acquisitions: Significant increases in ownership by a particular investor can signal confidence in the company's future.
• Divestitures: Large-scale selling can indicate concerns about the company's prospects.
• Activist Campaigns: Public announcements of activist investors taking positions and pushing for changes.

For more insights into Predictive Oncology Inc. (POAI)'s financial standing, you might find this link helpful: Breaking Down Predictive Oncology Inc. (POAI) Financial Health: Key Insights for Investors

Keeping an eye on these factors can provide valuable context for understanding Predictive Oncology Inc. (POAI)'s performance and potential investment risks and opportunities.

Predictive Oncology Inc. (POAI) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating Predictive Oncology Inc. (POAI). Shifts in major shareholdings and overall market perception can significantly impact the company's stock performance and future prospects. Examining these factors provides valuable insights for current and potential investors.

Predictive Oncology Inc. (POAI) is subject to various market forces and investor behaviors that influence its stock price. Monitoring these dynamics is essential for stakeholders aiming to make informed decisions.

Recent market reactions to Predictive Oncology Inc. (POAI) can be assessed by looking at stock performance following significant announcements or changes in ownership. Analyzing these patterns helps understand market confidence and potential volatility.

• Stock Volatility: Keep abreast of fluctuations in POAI's stock price, especially following major news releases or shifts in investor positions.
• Trading Volumes: Monitor trading volumes to gauge the level of interest and activity surrounding POAI shares.
• Market Sentiment: Track overall market sentiment through financial news, social media, and investor forums to understand the prevailing attitudes toward POAI.

Changes in ownership structure and the moves of large investors often trigger specific reactions in the stock market. These reactions can provide insights into how the market perceives the company's value and future potential.

Analyst perspectives play a crucial role in shaping investor sentiment and influencing market behavior towards Predictive Oncology Inc. (POAI). These insights often provide a deeper understanding of the company's prospects and potential risks.

• Earnings Forecasts: Analysts' predictions for POAI's future earnings can significantly impact investor expectations and stock valuation.
• Price Targets: Price targets set by analysts offer a benchmark for the potential future value of POAI shares.
• Investment Ratings: Analyst ratings (e.g., buy, hold, sell) reflect their overall assessment of POAI's investment attractiveness.

The table below summarizes key aspects of how analyst perspectives can impact investors.

For further insights into Predictive Oncology Inc. (POAI)'s financial standing, consider exploring this analysis: Breaking Down Predictive Oncology Inc. (POAI) Financial Health: Key Insights for Investors

Understanding the dynamics of investor sentiment, market reactions, and analyst perspectives is vital for anyone looking to invest in or follow Predictive Oncology Inc. (POAI). These elements collectively shape the market's view of the company and influence its stock performance.